Sanofi Could Turn Its Attention to BioMarin (BMRN) After Selling Regeneron Stake - RBC

May 26, 2020 8:24 AM EDT Send to a Friend
RBC Capital analyst Kennen MacKay speculated that Sanofi's (NYSE: SNY) sale the majority of its Regeneron (NASDAQ: REGN) stake could ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login